MULTIPLE MYELOMA KNOWLEDGE CENTER

What is Aplidin?

Aplidin (plitidepsin) is an anti-tumor agent being developed by PharmaMar that was originally isolated from a marine organism known as a sea squirt. Aplidin is given as an intravenous infusion every 2 weeks.